Insider · CIK 0001403497
Adam K Stern
director
Files at VIVS (VivoSim Labs, INC.), DRIO (DarioHealth Corp.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 18, 2025 | DRIO DarioHealth Corp. | CConversion Common Stockindirect: By AKS Family Partners L.P. | +11,760 | $40.40 | $475k | 17,906 | 15 d ago |
| Sep 18, 2025 | DRIO DarioHealth Corp. | CConversion Common Stockindirect: By AKS Family Partners L.P. | +8,435 | $16.60 | $140k | 26,341 | 15 d ago |
| Sep 24, 2026 | DRIO DarioHealth Corp. | AGrant or award Common Stock | +28,000 | $0.00 | $0 | 57,717 | 15 d ago |
| Sep 18, 2025 | DRIO DarioHealth Corp. | CConversion Series C Preferred Stockderivativeindirect: By AKS Family Partners L.P. | -250 | $1,000.00 | $250k | 0 | 15 d ago |
| Sep 18, 2025 | DRIO DarioHealth Corp. | CConversion Series D-2 Preferred Stockderivativeindirect: By AKS Family Partners L.P. | -100 | $1,000.00 | $100k | 0 | 15 d ago |
| Jan 27, 2026 | VIVS VivoSim Labs, INC. | AGrant or award Common Stock | +15,000 | $0.00 | $0 | 19,899 | Jan 29, 2026 |
| Sep 11, 2025 | DRIO DarioHealth Corp. | AGrant or award Common Stock | +20,000 | $0.00 | $0 | 29,717 | Sep 15, 2025 |
| Jan 7, 2025 | DRIO DarioHealth Corp. | POpen-market purchase Series D-2 Preferred Stockderivativeindirect: AKS Family Partners L.P. | +100 | $1,000.00 | $100k | 0 | Jan 10, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.